New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
07:48 EDTLH, MYGNMyriad cancer testing franchise to lose share, says Leerink
Leerink says Horizon Blue Cross Blue Shield's announcement that it is terminating its participation agreements with Myriad Genetics is consistent with its view that the company's core hereditary cancer testing franchise will experience market share and price erosion over time. Leerink notes defenders of Myriad had argued that the company remained in Horizon's network while LabCorp (LH) was the preferred provider, which will no longer be the case. It has a Market Perform rating on Myriad.
News For MYGN;LH From The Last 14 Days
Check below for free stories on MYGN;LH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 16, 2014
08:04 EDTLHLabCorp, ARCA Biopharma present GENETIC-AF poster at HFSoA meeting
Subscribe for More Information
September 15, 2014
07:21 EDTLHHeart Failure Society of America to hold annual meeting
Subscribe for More Information
September 9, 2014
07:11 EDTMYGNMyriad Genetics presented results from myPath Melanoma test clinical study
Subscribe for More Information
September 8, 2014
08:36 EDTLHARCA Biopharma, LabCorp announce GENETIC-AF poster presentation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use